John Patience
CIK: 0001021413
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Sep 30, 2026BDSX
BIODESIX INC
Exercise(M)Direct1.4K shares- - Jun 30, 2026BDSX
BIODESIX INC
Exercise(M)Direct1.4K shares- - Mar 31, 2026BDSX
BIODESIX INC
Exercise(M)Direct1.4K shares- - Jan 5, 2026BDSX
BIODESIX INC
Exercise(M)Direct1.1K shares- - Jan 2, 2026BDSX
BIODESIX INC
Award(A)DirectStock Options (Right to Buy)
6.4K shares- - Jan 2, 2026BDSX
BIODESIX INC
Award(A)DirectRestricted Stock Units
5.4K shares- - Sep 30, 2025BDSX
BIODESIX INC
Exercise(M)Direct1.1K shares- - Jun 30, 2025BDSX
BIODESIX INC
Exercise(M)Direct22.9K shares- - May 20, 2025BDSX
BIODESIX INC
Award(A)DirectRestricted Stock Units
68.6K shares- - May 20, 2025BDSX
BIODESIX INC
Award(A)DirectStock Options (Right to Buy)
42K shares- - Mar 31, 2025BDSX
BIODESIX INC
Exercise(M)Direct46.7K shares- - Dec 3, 2024AXDX
Accelerate Diagnostics, Inc
Purchase(P)Indirect200K shares at avg. $1.57$314K - Nov 5, 2024BDSX
BIODESIX INC
Purchase(P)Indirect75K shares at avg. $1.38$104K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 |  BDSX BIODESIX INC | Exercise(M) | 1,360 | - | $0 | Direct |
| Jun 30, 2026 | BDSX BIODESIX INC | Exercise(M) | 1,361 | - | $0 | Direct |
| Mar 31, 2026 | BDSX BIODESIX INC | Exercise(M) | 1,361 | - | $0 | Direct |
| Jan 5, 2026 | BDSX BIODESIX INC | Exercise(M) | 1,143 | - | $0 | Direct |
| Jan 2, 2026 | BDSX BIODESIX INC | Award(A) Stock Options (Right to Buy) | 6,354 | - | - | Direct |
| Jan 2, 2026 | BDSX BIODESIX INC | Award(A) Restricted Stock Units | 5,443 | - | - | Direct |
| Sep 30, 2025 | BDSX BIODESIX INC | Exercise(M) | 1,144 | - | - | Direct |
| Jun 30, 2025 | BDSX BIODESIX INC | Exercise(M) | 22,874 | - | - | Direct |
| May 20, 2025 | BDSX BIODESIX INC | Award(A) Restricted Stock Units | 68,621 | - | - | Direct |
| May 20, 2025 | BDSX BIODESIX INC | Award(A) Stock Options (Right to Buy) | 42,010 | - | - | Direct |
| Mar 31, 2025 | BDSX BIODESIX INC | Exercise(M) | 46,686 | - | - | Direct |
| Dec 3, 2024 |  AXDX Accelerate Diagnostics, Inc | Purchase(P) | 200,000 | $1.57 | $314,000 | Indirect |
| Nov 5, 2024 | BDSX BIODESIX INC | Purchase(P) | 75,000 | $1.38 | $103,710 | Indirect |
1-13 of 13 transactions
About PATIENCE JOHN
PATIENCE JOHN (SEC CIK 0001021413) files insider reports with the SEC as Director of BIODESIX INC (BDSX) and Director of Accelerate Diagnostics, Inc (AXDX).
Signal8 holds 10 ownership filings by PATIENCE JOHN, all Form 4s, filed between Nov 6, 2024 and Oct 2, 2026. Those filings report 13 transactions, from Nov 5, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on PATIENCE JOHN's filings is in LOUISVILLE, CO.
Recent filings by PATIENCE JOHN
- Sep 30, 2026: Option exercise of BDSX shares (Form 4, code M).
- Jun 30, 2026: Option exercise of BDSX shares (Form 4, code M).
- Mar 31, 2026: Option exercise of BDSX shares (Form 4, code M).
- Jan 5, 2026: Option exercise of BDSX shares (Form 4, code M).
- Jan 2, 2026: Grants or awards of BDSX derivative securities (2 lines, Form 4, code A).
Other insiders filing for BIODESIX INC (BDSX)
- SCHULER JACK W, 10% Owner
- Pestano Gary Anthony, Chief Development Officer
- O'Kane Kieran, Chief Commercial Officer
- Cowie Robin Harper, CFO, Sec'y & Treasurer
- Vazquez Chris, Chief Accounting Officer
- Hutton Scott, President & CEO